-
Taxonomy & unit
-
us-gaap: GBP
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
TC BioPharm (Holdings) plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2022 to 2023.
- TC BioPharm (Holdings) plc Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -£111K, a 72.3% increase year-over-year.
- TC BioPharm (Holdings) plc annual Income Tax Expense (Benefit) for 2023 was -£1.09M, a 36.7% increase from 2022.
Income Tax Expense (Benefit), Annual (GBP)
Income Tax Expense (Benefit), YoY Annual Growth (%)